Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Welltower (WELL)

NYSE: WELL · REIT—Healthcare Facilities · Toledo, OH

Our rating: Neutral

Neutral reaffirmed at $227.20, moderate conviction, October 28, 2026.

Breaks if: The Neutral call turns Positive if FCF reaches $3.5B or above on a trailing four-quarter basis — implying a FCF yield above 2.1% at today's market cap — while revenue growth holds above 15% YoY; it turns Cautious if revenue growth decelerates below 10% YoY in either of the next two quarterly filings, or if reported free cash flow falls below $2.0B on a trailing basis within the next four quarters.

Key figures

Market value$176.3B
Revenue, last 12 months$11.4B
Net income, last 12 months$1.7B
Free cash flow, last 12 monthsn/a
Price to earnings100.9×
Free cash flow yieldn/a
Dividend yield1.3%
Operating marginn/a
Return on equity4.0%
Beta to the S&P 5000.21
Volatility, annualized21.7%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$3.1B51.4%$0.54n/a
June 30, 2026$3.0B51.4%$0.61n/a
March 31, 2026$2.8B49.1%$1.02n/a
December 31, 2025$2.6B45.1%$0.13n/a
September 30, 2025$2.1B36.4%$0.41n/a
June 30, 2025$2.0B41.4%$0.45n/a
March 31, 2025$1.9B37.1%$0.40n/a
December 31, 2024$1.8B39.5%$0.18n/a

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

13 ledger entries and 45 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.